Read our statement sharing principles to follow for equitable access to medical tools for Ebola disease caused by Bundibugyo virus: msfaccess.org/principles-e...
“A more equitable system can begin today if governments choose to act on the commitments they have already made in the Pandemic Agreement.”
MSF statement at #WHA79, delivered by Yuanqiong Hu, Head of Analysis, MSF Access.
Read the full statement: msfaccess.org/open-ended-i...
🥁 We’re continuing our drumbeat call of analogue insulin pens for all at #WHA79.
It’s time for countries & @who.int to end the double standard in diabetes care and include analogue insulin pens and glucose monitoring devices in all diabetes guidelines.
msfaccess.org/follow-polit...
With no validated treatments or vaccines yet, and limited diagnostics for Bundibugyo virus disease, R&D and funding must embed transparent and enforceable conditions from the outset to guarantee timely, sustainable access to affordable medical tools for the most affected communities.
#Ebola outbreaks: There are currently no approved vaccines or treatments available for the #Bundibugyo virus.
Our teams, along the Democratic Republic of Congo’s MOH are working to contain the spread of the disease and strengthen patient care: www.doctorswithoutborders.ca/democratic-r...
Cancer is becoming one of the most serious health challenges in Papua New Guinea. Patients often come in late for care, and there is limited capacity for diagnosis and treatment.
Our new cancer initiative in Morobe province is addressing gaps in care:
👋 Meet Nombuso Ntshalintshali, our laboratory manager at Sitsandziwe clinic in Eswatini!
Her lab uses a ‘test and treat’ approach, giving fast, accurate results for sexually transmitted infections so that patients can get targeted medications that reduce the risk of antibiotic resistance.
In eastern DRC, our teams are working to contain the spread of the Ebola disease outbreak and strengthen patient care, alongside the Ministry of Health.
Learn about our response so far:
🚨 Ebola in DRC
Our teams are scaling up our response to the Ebola disease outbreak in DRC.
How are we responding?
What's different about this outbreak?
Why are we concerned?
Read the answers here ⬇️
Why is this Ebola disease outbreak different?
John Johnson, our medical lead for epidemic response, gave an interview to explain the Bundibugyo virus and its challenges:
Video
MSF calls for following R&D Principles for equitable access to medical tools for Bundibugyo virus
A new MSF project in Papua New Guinea is strengthening cancer care, including palliative care, at ANGAU Memorial Provincial hospital, in collaboration with local authorities.
msf.me
In Democratic Republic of Congo, MSF teams are scaling up our response to the Ebola disease outbreak.
In an interview, John Johnson, MSF's medical lead for epidemic response, explains the Bundibugyo virus and what makes this Ebola disease outbreak different.
